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        CD8 is an important coreceptor for TCR during 
CD8 T cell activation by peptide/class I MHC 
ligands (  1  –  4  ). CD8 engagement can enhance 
peptide sensitivity by 1 million  –  fold or more (  2  ), 
and it is required for a stable complex between 
class I and the TCR (  5, 6  ). CD8 expression has 
been thought to be stable during a CD8 T cell 
re  sponse, and it is commonly used as the marker 
to defi  ne cytotoxic T cells. However, CD8 ex-
pression can be inhibited by certain cytokines, 
including IL-2, -4, and -15, on activated T cells 
(  7  –  11  ). Furthermore, down-regulation of CD8 
has been suggested as one of the mechanisms 
for peripheral tolerance (  12  –  15  ). CD8 low sub-
populations have been reported during chronic 
diseases (  16  –  18  ), but CD8 down-regulation also 
occurs during acute immune responses to patho-
gens (  19  –  21  ) and cell lines (  22  ). In the current 
study, we use both viral and bacterial infection 
models to investigate the underlying mechanism 
and consequences of transient CD8 down-regu-
lation during acute infections. 
  Tetramer staining is an effi   cient tool to de-
fi  ne Ag-specifi  c CD8 T cells in infections and 
tumors, and tetramer binding correlates well with 
antigen-specifi  c IFN-      production and cytolytic 
activity (  23  –  26  ). However, class I MHC tetramer 
binding to specifi  c T cells can be aff  ected by TCR 
expression levels, CD8 availability, and distribu-
tion of TCR on the cell surface (  27  –  35  ). Some 
studies suggest that CD8 T cell activation en-
hances binding of specifi  c peptide/MHC ligands 
(  36  ) and functional avidity of the maturing CTL 
population (  21  ). However, other studies report 
that CD8 T cell activation results in a loss of 
peptide/MHC ligand binding (  34, 35, 37  ) and 
accompanying impaired functional sensitivity (  34  ). 
However, the role of CD8 down-regulation in 
infl  uencing tetramer binding and/or functional 
sensitivity is still unclear. 
  In this study, we investigate the basis and 
impact of CD8 down-regulation during immune 
responses to LM and vaccinia virus (VV). Tran-
sient down-regulation of CD8 expression was 
correlated with loss of specifi  c peptide/MHC 
tetramer binding and impaired responsiveness 
of CD8 T cells to antigen. We demonstrate that 
down-regulation of CD8 expression (and loss of 
specifi  c peptide/MHC tetramer binding) during 
the response to LM is dependent on CD8 T cell 
responsiveness to type I interferon (IFN-I), indi-
cating that infl  ammatory cues may act to limit 
the reactivity (i.e., detune) eff  ector CD8 T cells, 
potentially to limit tissue damage. 
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antigen was also required for CD8 loss. These results suggest that CD8 effector T cell differen-
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suggested CD8 down-regulation was induced by prolonged 
encounter with specifi  c antigen (  12  –  15  ), but it has also been 
observed during acute infections (  19  –  21  ). We examined the 
response of OT-I TCR transgenic T cells after adoptive trans-
fer into normal B6 hosts and after infection with recombinant 
VV-expressing OVA peptide (VV-OVAp). As noted in pre-
vious reports (  19, 21  ), we observed down-regulation of CD8 
expression on OT-I T cells in the spleen during the in vivo 
response, peaking at day 7 of activation (  Fig. 1 A  ).   CD8 down-
regulation was also observed on responding OT-I cells in LNs 
and the peritoneal cavity (unpublished data). CD8 down-reg-
ulation also occurred, with similar kinetics, after LM-OVA 
infection (  Fig. 1 B  ). The extent and kinetics of CD8 down-
regulation is summarized in   Fig. 1 C  , which shows      70% 
reduction in CD8 expression after VV-OVAp and LM-OVA 
infection (at day 7;   Fig. 1 C   and not depicted). Interestingly, 
the kinetics of CD8 down-regulation did not correlate with the 
kinetics of clonal expansion because clonal expansion was dif-
ferent in the two infections, peaking at day 5 for VV infection, 
and day 7 for LM infection (Fig. S1, available at http://www.jem
.org/cgi/content/full/jem.20062376/DC1). 
  To address whether down-regulation of CD8 results from 
reduced transcription of CD8      and/or      , OT-I cells were 
sorted from recipient mice at various time points after infection 
with VV-OVAp and compared with naive OT-I cells for levels 
of CD8      and       transcripts, which were quantifi  ed using real-
time RT-PCR. Similar to   Fig. 1 A  , there was uniform down-
regulation of CD8 on the population of day 5  –  activated OT-I 
cells, and this eff  ect was even more pronounced at day 7 (not 
depicted). However, although we observed changes in expres-
sion of GAPDH with OT-I T cell activation (as expected based 
on previous studies; reference [ 38  ]), there were minimal changes 
in mRNA levels for either CD8 chain (  Fig. 1 D  ), suggesting 
that the appearance of the prominent CD8  low   pool by day 7 of 
activation was not a result of reduced CD8           transcript levels. 
Thus, although the mechanism for regulating CD8 expression 
levels is currently unclear, it is likely to be posttranscriptional. 
  Tetramer binding is down-regulated during primary 
infections and correlates with decreased CD8 expression 
  Tetramer binding to TCR has become a powerful tool for 
defi  ning Ag-specifi  c CD8 T cells (  23  –  26  ). Given that specifi  c 
peptide/class I MHC binding can be infl  uenced by the avail-
ability of CD8 (  29, 39  ), we sought to test whether the ob-
served down-regulation of CD8 on antigen-activated T cells 
infl  uences specifi  c tetramer binding. Indeed, we observed a 
marked decrease in specifi  c tetramer staining on OT-I T cells 
primed with VV-OVAp and LM-OVA (  Fig. 2, A and B  ).   
Loss of specifi  c tetramer staining was fi  rst noticed at day 5 and 
peaked at day 7 (  Fig. 2, A-C  ). Tetramer binding was reduced 
by      70% in VV-OVAp and LM-OVA infection at day 7 after 
infection (  Fig. 2 C   and not depicted). Thus, in vivo  –  stimu-
lated T cells show a marked loss in specifi  c tetramer staining, 
and this follows the same kinetics as the loss in CD8 expression 
levels. Linear regression analysis demonstrated a statistically 
signifi  cant direct correlation between tetramer binding and 
    RESULTS   
  CD8 expression is down-regulated during immune response 
by nontranscriptional regulation 
  CD8 has been shown to be a critical coreceptor in TCR com-
plex formation during T cell activation, and its expression has 
long been used as a marker for cytotoxic T cells. Previous studies 
  Figure 1.     CD8 expression is down-regulated on responding T cells 
during viral and bacterial infections. Ly5.2 mice adoptively transferred with 
naive OT-I.PL T cells were inoculated with 5       10 6   PFU VV-OVAp per mouse, or 
10  4   LM-OVA i.p. At the indicated time points, spleens were harvested, and OT-I 
and endogenous CD8 T cells were identifi  ed using CD8 and Thy 1.1 staining. 
Representative staining of CD8 levels on OT-I cells after VV-OVAp (A) infection 
or LM-OVA (B) infection are shown. Dashed lines indicate CD8 expression 
levels of uninfected controls and OT-I cells at day 7 of infection. (C) Kinetics of 
CD8 down-regulation in infections. Each of the values represents the mean 
of three or more mice, and error bars represent the SD. Data are representative 
of more than four experiments. (D) OT-I.PL cells were adoptively transferred 
and primed with VV-OVAp, as described. At days 3, 5, and 7 after infection, 
OT-I cells were sorted from the spleen and RNA isolated. Naive OT-I CD8 T cells 
were sorted as a control. Equivalent amounts of total RNA were used for 
generation of cDNA, and real-time PCR was used to quantify expression of 
CD8    ,  CD8    , and GAPDH. Each column represents the fold change compared 
with naive samples, and the experiment was repeated with similar results.    JEM VOL. 204, October 29, 2007 
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observed (Fig. 1), down-regulation of CD8 expression was 
most marked at day 7 after infection, but CD8 levels had par-
tially recovered at day 14 and were back to control (naive) 
levels by day 21 after infection (  Fig. 3, A and B  ).    
  Again, regulation of specifi  c tetramer binding paralleled 
the changes in CD8, rather than TCR expression levels (  Fig. 
3, C  –  F  ), which is similar to our observations for down-regu-
lation of tetramer binding during priming. Therefore, our 
data indicate re  covery of CD8 expression, and also specifi  c 
CD8 expression; high tetramer binding correlated with high 
CD8 expression, and vice versa (Fig. S2, A and B, available at 
http://www.jem.org/cgi/content/full/jem.20062376/DC1). 
To address if this tetramer-binding down-regulation was also 
related to TCR expression levels, TCR expression was ex-
amined in both models (Fig. S3). Interestingly, TCR levels 
on stimulated OT-I cells were maintained at days 3 and 5 in 
the spleen, and the slight decline in TCR expression observed 
in the spleen at day 7 was not found in OT-I cells from LNs 
or the peritoneal cavity (Fig. S3, A  –  D). Together, these 
data indicate that loss of peptide/MHC tetramer binding cor-
relates with down-regulation of CD8, rather than changes in 
TCR expression. 
  Down-regulation of CD8 expression and tetramer binding 
are transient 
  A previous study of LM-reactive T cells reported that CD8 
down-regulation was sustained, lasting well into the mem-
ory phase of the response (  19  ). However, CD8 levels on bulk 
memory CD8 T cells are similar to those on the naive pool 
(unpublished data). To address this issue in our system, we 
studied the kinetics of CD8 reexpression during OT-I re-
sponses to VV-OVAp and LM-OVA infection. As previously 
  Figure 2.     Tetramer binding is down-regulated in viral and bacte-
rial infections. OT-I adoptive transfer and infections were performed as 
in   Fig. 1  . Spleen cells were stained with K  b  /OVA tetramer. Representative 
K  b  /OVA staining on OT-I cells after VV-OVAp infection (A) or LM-OVA in-
fection (B) are shown. Dashed lines indicate mean tetramer staining levels 
of uninfected controls and OT-I cells at day 7 of infection. (C) Kinetics of 
loss of tetramer binding during infections. Each of the values represents 
the mean of three or more mice, and error bars represent the SD. These 
data are representative of at least three experiments.     
  Figure 3.     Down-regulation of CD8 expression and tetramer bind-
ing is transient. Adoptive transfer and infections were performed as in 
  Fig. 1  . Representative histograms are shown for CD8 expression (A and B) 
K  b  /OVA tetramer binding (C and D) and OT-I TCR expression (E and F) on 
OT-I cells after VV-OVAp (A, C, and E) or LM-OVA (B, D, and F) for the indi-
cated time points. These data are representative of three animals per 
group from two independent experiments.     2670 IFN-I INFLUENCES CD8 DOWNREGULATION ON ACTIVATED T CELLS | Xiao et al.
tetramer staining, during diff  erentiation of CTL into the late 
eff  ector/memory pool. 
  Figure 4.     CD8 T cells with low CD8 expression show decreased 
responsiveness to antigen. OT-I effector T cells (primed as in   Fig. 1  ) and 
memory OT-I cells (see Materials and methods) were challenged with indi-
cated doses of OVAp (A and B) or N6 peptide (C) in vitro for 3.5 h, fol-
lowed by intracellular staining for IFN-     . Histograms show the percentage 
of IFN-         OT-I cells (A and C) or the percentage of maximum response (B) 
as a function of peptide concentration. OVAp response of day 3 and 7 
effector cells is representative of 4 experiments, and assay of memory OT-I 
response and N6 reactivity was repeated with similar results. Each value 
represents the mean plus the SD of 3  –  4 mice per group. Asterisks indicate 
statistical signifi  cance. *, P       0.05; **, P       0.01; ***, P       0.001.   
  CD8 down-regulation accompanies reduced responsiveness 
to antigen 
  Because day 7  –  activated CD8 T cells showed both diminished 
CD8 expression and reduced tetramer-binding ability (  Fig. 1 
and Fig. 2  ), it was important to determine whether these 
changes lead to altered functional responses. Spleens were har-
vested from mice adoptively transferred with OT-I T cells and 
infected with VV-OVAp either 3 or 7 d earlier, and CD8 
down-regulation was observed on cells from the latter time 
point, similar to that observed in   Fig. 1   (not depicted). The 
splenocytes were then stimulated with serially diluted OVAp, 
or a variant of this peptide (called N6), which we have previ-
ously shown is a weak agonist for the OT-I TCR (  40  ). Produc-
tion of IFN-     by the OT-I cells was determined via intracellular 
staining (  Fig. 4  ).   At the maximum dose of OVAp tested, the 
percentage of IFN-       –  positive OT-Is was     70% in the CD8  high   
(day 3 after infection) and     50% in the CD8  low   (day 7 after 
infection) populations (  Fig. 4 A  ), demonstrating that fewer 
CD8  low   cells were able to respond. Furthermore, a higher con-
centration of OVAp was required for half-maximal respon-
siveness by the CD8  low   day 7 cells compared with the CD8  high   
day 3 pool (  Fig. 4 B  ), leading to a slight but consistent 2  –  5-fold 
lower dose sensitivity of the day 7 eff  ector OT-I cells, relative 
to the day 3 population (  Fig. 4, A and B,   and not depicted). 
Finally, the per cell production of IFN-      was also greater 
in the day 3 eff  ector pool, as revealed by the average mean 
fl  uorescence intensity (MFI) of intracellular IFN-      staining 
(Fig. S4, available at http://www.jem.org/cgi/content/full/jem
.20062376/DC1). Such changes in sensitivity were further 
magnifi  ed when the response to the OT-I N6 peptide was 
studied. This weak agonist variant of the OVA peptide was ca-
pable of inducing IFN-      production by cells in the day 3 OT-I 
eff  ector pool, but this response was severely reduced in the 
day 7 eff  ector population (  Fig. 4 C  ). Together, these data indicate 
that both the frequency of cells capable of responding to a given 
dose of antigen, and the effi   cacy of that response is decreased in 
eff  ector cells from day 7 relative to the population from day 3. 
  Previous studies have argued for functional avidity matura-
tion of the CD8 response, such that the sensitivity of T cells 
to specifi  c peptide/MHC ligands was proposed to increase by 
over 50-fold from early eff  ector cells (day 2/3) to the late eff  ec-
tor (day 8) stage (  21  ). Our fi  ndings above, showing reduced 
functional avidity for day 7 versus day 3 OT-I eff  ector cells, 
appeared to contradict this model. However, it was possible 
that the functional sensitivity of OT-I cells would increase as 
the cells completed maturation into the memory pool because 
previous reports indicated that high functional avidity was 
maintained into the memory phase (  21  ). To address this, we 
also tested the sensitivity of memory OT-I cells in the same ex-
periments (  Fig. 4, A and B  ). These studies revealed that day 3 
eff  ector and memory OT-I cells had similar frequencies of 
IFN-       –  producing cells and similar dose sensitivity (both of 
which were high, relative to day 7 eff  ector population). There-
fore, our data suggest a transient dip in antigen sensitivity as 
CD8 T cells pass through the late eff  ector phase, rather than a 
progressive rise in functional avidity during diff  erentiation. JEM VOL. 204, October 29, 2007 
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transferred WT OT-I showed     40% down-regulation of CD8 
expression (  Fig. 5 A  ).   CD8 down-regulation after LM-OVA 
infection correlated with expression of IFN-IR because IFN-
IR       /       OT-I also failed to show CD8 down-regulation after 
activation, whereas IL-12R     1       /       OT-I cells exhibited CD8 
down-regulation similar to the WT controls (  Fig. 5 A  ). Rela-
tive to naive controls, day 7  –  activated IFN-IR       /       OT-I failed 
to show down-regulation of either CD8 levels (  Fig. 5 B  ) or 
K  b  /OVA tetramer binding (  Fig. 5 C  ), whereas cotransferred 
WT OT-I showed down-regulation of staining with both re-
agents (  Fig. 5, B and C  ). This autonomous resistance to CD8 
loss by the IFN-IR       /       cells during LM infection was not 
caused by a diff  erence in kinetics of CD8 down-regulation be-
cause the CD8 levels were maintained (or even increased) rela-
tive to controls over several time points (  Fig. 5 D  ). However, 
production of IFN-      was not enhanced in eff  ector IFN-IR       /  −    
  Regulation of CD8 expression is IFN-I dependent 
  IFN-I has been shown to act directly on CD8 T cells to pro-
mote the survival of CD8 eff  ectors (  41  ), and both IFN      and 
IL-12 have been reported to be involved in the activation of 
CTLs as third signals (  42, 43  ). Hence, we considered whether 
IFN-I and/or IL-12 were also involved in CD8 down-regula-
tion. To test this, WT OT-I T cells and OT-I T cells defi  cient 
for IFN-IR, IL-12R     1, or both cytokine receptor (double 
KO [DKO]) T cells were cotransferred into normal B6 ani-
mals. Recipient mice were infected with LM-OVA and as-
sayed at day 7. At this time point, the numbers of IFN-IR and 
DKO OT-I cells were reduced compared with their WT 
counterparts (by     20 and     60%, respectively; unpublished 
data), which is consistent with previous reports (  44  ), but this 
still provided ample eff  ector stage cells for analysis. The DKO 
OT-I showed almost no CD8 down-regulation, whereas co-
  Figure 5.     Down-regulation of CD8 expression in response to LM-OVA infection is IFN-I dependent. Purifi  ed naive CD8 T cells from OT-I.PL and 
the indicated cytokine receptor KO OT-I strains were adoptively transferred into CD45.1 congenic B6 mice, and the host animals were infected with 
LM-OVA. 7 d later, recipient spleens were harvested, and WT and receptor KO OT-I cells (distinguished by staining for CD45.2 and Thy 1.1) were analyzed. 
(A) CD8 expression on cotransferred WT and receptor KO OT-I cells. The MFI of each group was expressed as the percentage of the MFI of CD8 staining of 
OT-I cells from uninfected mice. In a different experiment, CD8 expression (B) and K  b  /OVA tetramer staining (C) were compared for cotransferred WT and IFN-
IR      /      OT-I cells at day 7 after LM-OVA infection. Individual square symbols show CD8 expression and tetramer binding on WT and IFN-IR      /      OT-I cells in 
uninfected controls. (D) CD8 expression on WT and IFN-IR      /      OT1 cells as a function of time after LM-OVA infection. Dashed line represents WT cells, solid 
line represents IFN-IR      /      cells. (E and F) Cotransferred WT and IFN-IR      /      OT-I cells were analyzed for antigen sensitivity at day 7 after LM-OVA infection. 
Cells were stimulated as in   Fig. 4  , and the percentage of IFN-       –  positive OT-I cells (E) or the percentage of maximum IFN-      responsiveness (F) was deter-
mined. The graphs show average responses (and SD) for three mice per group, and similar data were observed in three experiments. Stars indicate signifi  -
cant differences (P       0.05).   2672 IFN-I INFLUENCES CD8 DOWNREGULATION ON ACTIVATED T CELLS | Xiao et al.
the frequency of antigen-specifi  c cells capable of producing 
IFN-      in response to antigen at this time point. Thus, antigen-
specifi  c endogenous CD8 T cells behave similarly to OT-I cells 
in regard to CD8 expression, tetramer binding, and changes in 
responsiveness during in vivo responses to VV-OVAp. 
    DISCUSSION   
  In this study, we showed that CD8 expression, peptide/MHC 
class I tetramer binding, and functional reactivity are all tran-
siently down-regulated during eff  ector diff  erentiation of CD8 
T cells responding to pathogens in vivo. This   “  detuning  ”   of 
eff  ector cells was observed for both TCR transgenic OT-I cells 
and endogenous polyclonal K  b  /OVA-specifi  c CD8 T cells, 
and in response to both VV and LM infections. Additional 
studies suggest OT-I T cells responding to OVA-expressing 
tumor cells show a similar decline in CD8 staining and tetramer 
binding (unpublished data), arguing that these changes occur 
with diverse immune challenges. 
  Primed CD8 T cell populations exhibiting low CD8 ex-
pression levels have been previously noted, in both humans 
and mice (  7  –  11, 15  –  22  ). However, the consequences of this 
OT-I compared with their WT counterparts (  Fig. 5, E and F  ), 
suggesting that factors other than CD8 and peptide/MHC 
ligand binding may impact IFN-      production, and/or that 
signals through the IFN-IR are required not only for the CD8 
regulation but also for the optimal production of IFN-     . 
  IFN-I  –  regulated CD8 loss is antigen dependent 
  The aforementioned data suggested that response to IFN-I was 
involved in CD8 down-regulation. We considered that this 
may be a direct response to IFN-I that is independent of TCR 
stimulation. To test this, we used poly I:C as a potent inducer 
of IFN-I (  45  ), injected with or without antigen (OVAp) into 
mice adoptively transferred with OT-I T cells. IFN-I is known 
to induce CD69 up-regulation on T cells, regardless of TCR 
specifi  city (  46, 47  ), and we observed that all CD8 T cells be-
came CD69  +   at 1 d after immunization (unpublished data), in-
dicating induction of IFN-I by the injected poly I:C. However, 
CD8 down-regulation only occurred in OT-I T cells from 
mice receiving poly I:C with peptide, not in mice receiving 
poly I:C alone (  Fig. 6, A and B  ), suggesting that CD8 down-
regulation requires antigen stimulation.   The kinetics of CD8 
down-regulation was similar to that observed in VV- and LM-
infected animals (compare   Fig. 6   to   Fig. 1  ). We could also 
show, using IFN-IR       /       OT-I T cells, that the CD8 down-
regulation after poly I:C plus peptide immunization required 
IFN-I sensitivity by the T cells themselves (  Fig. 6 C  ), which is 
consistent with the results in LM-OVA infection (  Fig. 5  ). 
  Endogenous CD8 T cells exhibit down-regulation of CD8 
expression, tetramer binding, and responsiveness 
during activation 
  Although TCR transgenic cell adoptive transfer models are 
valuable for tracking immune response in vivo, it was possible 
that the loss of CD8 expression, engagement with tetramer, 
and reduced responsiveness of day 7  –  activated OT-I cells re-
lated to their abnormal frequency in the immune response. 
Thus, we also studied endogenous CD8 T cell responses to 
K  b  /OVA. Normal B6 mice were infected with VV-OVAp 
and studied for CD8 expression levels and K  b  /OVA tetramer 
binding at day 5 (when suffi   cient antigen-specifi  c cells could 
fi  rst be detected) and day 7 after infection. As for the OT-I ex-
periments, we observed down-regulation of both CD8 expres-
sion and K  b  /OVA tetramer binding at day 7 relative to day 5 
(  Fig. 7, A and B  ).   Similar to what has been reported previously 
for OT-I cells (  31  ), tetramer binding to the polyclonal re-
sponder CD8 T cells was strictly CD8 dependent, being com-
pletely blocked by antibody to CD8 (  Fig. 7 C  ). In addition, we 
tested responsiveness of endogenous K  b  /OVA-specifi  c CD8 T 
cells at days 5 and 7 after VV-OVAp infection (  Fig. 7 D  ). As 
was the case for OT-I cells, the frequency of IFN-       –  producing 
CD8 cells was signifi  cantly higher in cells assayed at day 5 com-
pared with day 7, whereas the frequency of antigen-specifi  c 
cells (i.e., OVA/K  b   tetramer staining cells) was not signifi  cantly 
diff  erent between the groups (  Fig. 7 D  ). Together with the 
observation that tetramer binding to day 7  –  responsive cells was 
also reduced (  Fig. 7 A  ), these data suggest a marked decrease in 
  Figure 6.     CD8 down-regulation is not induced by IFN-I alone. 
(A and B) Mice were adoptively transferred with WT OT-I cells and immu-
nized with poly I:C with or without OVAp. At the indicated time point, 
spleens were harvested and CD8 expression and levels were analyzed. 
(A) The average CD8 expression levels (the mean       the SD) on splenocytes 
from 3  –  4 mice per group are shown. Open symbols represent immuniza-
tion with poly I:C alone, whereas closed symbols show responses induced 
by poly I:C plus OVAp. (B) Representative histograms from these same 
groups. (C) WT and IFN-IR      /      OT-I cells were cotransferred and studied for 
CD8 expression levels 5 d after poly I:C plus OVA peptide immunization.     JEM VOL. 204, October 29, 2007 
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CD8 down-regulation is routinely observed on stimulated T 
cells responding to pathogens in vivo (  19  –  21  ), speaks to its 
potential signifi  cance. 
  Our data suggest that activated CD8 T cells pass through a 
phase (peaking at approximately day 7 of activation) during 
which their ability to engage and respond to peptide/MHC 
antigens is impaired. This appears to contrast with a previous 
study suggesting increased sensitivity of CD8 T cells as they 
diff  erentiate. Slifka and Whitton, studying the response to 
LCMV, reported a progressive increase in functional avidity 
(i.e., peptide/MHC sensitivity) throughout the eff  ector phase, 
reaching peak sensitivity at day 8 of infection, which was then 
sustained into the memory pool (  21  ). For endogenous, poly-
clonal CD8 T cells, this lead to a substantial increase (     50-
fold) in antigen sensitivity between days 4 and 8 after infection 
(  21  ). This fi  nding may involve a strong component of TCR 
repertoire selection because the increase in functional avidity 
of a monoclonal T cell population (P14 TCR transgenic T 
cells) was much less substantial, increasing only approximately 
threefold between the same time points (  21  ). Nevertheless, our 
data with K  b  /OVA CD8 T cells (both monoclonal [  Fig. 4  ] and 
polyclonal [  Fig. 7  ] populations), demonstrated reduced, rather 
than enhanced, sensitivity of the day 7 eff  ector pool. Further-
more, we were unable to demonstrate an increase in functional 
avidity, as OT-I T cells progress from the early eff  ector phase 
(day 3 of activation) into the memory phase (  Fig. 4  ), suggesting 
that functional avidity maturation is not a feature of our sys-
tem. The basis for these distinct outcomes is currently unclear. 
Slifka and Whitton correlated functional avidity maturation 
with progressively increased CD8 independence (  21  ). How-
ever, we fi  nd that both OT-I T cells (  31, 35  ) and polyclonal 
K  b  /OVA-reactive cells (  Fig. 7  ) exhibit substantial CD8 depen-
dence for peptide/MHC tetramer binding. The diff  erent 
MHC class I alleles used in our model (K  b  ) versus Slifka and 
Whitton  ’  s study (D  b  ) may impact the CD8 dependence of the 
T cell response. However, CD8 dependence in peptide/MHC 
ligand engagement and/or responsiveness has been reported 
for cells restricted through many mouse class I alleles (  10, 48  –  50  ), 
including the D  b  /LCMV gp33-responsive P14 clone (  33  ), and 
has also been observed for human CTL (  51, 52  ). This raises 
the important point that CD8-independent clones might be 
expected to show a selective advantage in overcoming the 
transient decrease in peptide/MHC ligand recognition re-
ported here. On the other hand, the proposed decreased CD8 
dependence during maturation of the eff  ector response (  21  ) 
does not appear to apply in all systems, as some authors report 
the opposite trend (  50, 53  ). In summary, our data do not sup-
port a model in which functional avidity progressively increases 
during the eff  ector response, but rather argues for a transient 
  “  dip  ”   in functional sensitivity in the late eff  ector pool. 
  Fahmy et al. reported that the avidity of TCR engagement 
was enhanced by 20- to 50-fold on in vitro  –  activated 2C CD8 
T cells compared with naive T cells, which was not related to 
changed expression of CD8 and TCR level, but rather to in-
creased cross-linking of TCR on activated T cells (  36  ). This also 
contrasts with the decreased tetramer binding and sensitivity of 
down-regulation for antigen recognition have not been exten-
sively studied. We demonstrate that the magnitude and kinet-
ics of CD8 down-regulation correlated well with decreased 
binding of specifi  c peptide/MHC tetramers (whereas the small 
changes in TCR expression levels did not correlate with loss 
of tetramer staining;   Fig. 2   and Fig. S3). We and others have 
previously reported that CD8 T cells cultured in vitro showed 
a transient decrease of specifi  c tetramer staining (  34, 35, 37  ). 
Drake et al. and Spencer and Braciale also demonstrated loss of 
tetramer binding to CD8 T cells primed by infl  uenza virus in-
fection in vivo (  34, 37  ), and found that this resulted in dimin-
ished functional sensitivity (  34, 37  ). However, these studies 
correlated changes in tetramer binding to altered surface TCR 
organization (  34  ) or CD8 glycosylation (  35  ), rather than 
changes in CD8 (or TCR) expression levels. This might sug-
gest that there are multiple pathways that can regulate tetramer 
binding and functional sensitivity, of which CD8 down-regu-
lation is but one mechanism. However, the observation that 
  Figure 7.     Endogenous CD8 T cells exhibit regulation of CD8 
expression, tetramer binding, and antigen sensitivity. B6 mice were 
infected with VV-OVAp and spleens were analyzed 5 and 7 d after infec-
tion. Peptide-specifi  c CD8 T cells (defi  ned by K  b  /OVA tetramer staining) 
were analyzed for the level of tetramer binding (A) and CD8 expression 
level (B). (C) The CD8 dependence of tetramer binding at both time points 
was assessed by addition of blocking anti-CD8      antibody. Each column or 
dot represents an average of three or four mice, and error bars indicate 
the SD. (D) Antigen sensitivity of K  b /OVA-specifi  c endogenous CD8 T cells 
was assessed by stimulation for IFN-      production, as in   Fig. 4  . The per-
centage of IFN-      producing CD8 T cells as a function of OVAp concentration 
is indicated on the left side of the graph. On the right side, the percentage 
of K  b  /OVA tetramer-positive cells is indicated, to refl  ect the frequency of 
antigen-specifi  c cells in the populations. Data show the average (plus the SD) 
of three mice per group, and similar fi  ndings were observed in an inde-
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(leading to CD8 loss via other signaling pathways), or may pro-
mote survival of CD8  low   T cells at the eff  ector stage. These hy-
potheses are not excluded by our current data, although it is 
worth reiterating that IFN-IR defi  ciency only moderately im-
pairs expansion of CD8 T cells after LM infection (unpublished 
data) (  44  ), arguing against dramatic diff  erences in initial T cell 
stimulation or survival of eff  ector cells. Nonetheless, although 
our data show that reactivity to IFN-I is involved in loss of 
CD8 expression during LM infection, its mode of action is 
unclear. The kinetics of IFN-I production relative to induced 
CD8 down-regulation (and loss in tetramer binding) are puz-
zling; previous studies have indicated that serum levels of IFN-I 
peak at     24  –  48 h after stimulation with various pathogens or 
poly I:C (  44  ), whereas we observe the peak of CD8 loss to oc-
cur approximately on day 7. These diff  erences might indicate 
that early IFN-IR signals (on the responsive CD8 T cells them-
selves) program loss of CD8 expression some days later. In this 
context, it is important to note that our data suggest loss of sur-
face CD8 was not a consequence of decreased mRNA expres-
sion (  Fig. 1 D  ), suggesting the regulation may relate to protein 
production or turnover. Further studies will be required to de-
termine the mechanism of cell surface CD8 loss, and whether 
IFN-I signals are directly involved in this process. 
  Although our results argue that IFN-I plays an important 
role in driving CD8 down-regulation in response to LM, they do 
not exclude a role for alternative cytokines in other responses. 
We have found that coinjection of peptide antigen, along with 
recombinant IL-12, stimulates some down-regulation of CD8 
and tetramer binding (unpublished data), although further work 
will be required to determine whether this involves a direct 
response of the T cells to IL-12. Because CD8 down-regula-
tion has been observed in a variety of responses (  7  –  11, 15  –  22  ), 
it might be anticipated that more than one infl  ammatory cyto-
kine could contribute to the process. 
  In summary, our data indicate that the CD8 T cells under-
going in vivo response to pathogens undergo a transient decline 
in CD8 expression, specifi  c tetramer binding, and functional 
sensitivity. These data argue that the reactivity of eff  ector CTL 
is subject to detuning during normal immune responses, which 
may enhance maintenance of the most   “  fi  t  ”   responder cells and 
limit collateral damage to the host. 
    MATERIALS AND METHODS   
  Mice, cell lines, and reagents.     OT-I mice with a transgenic TCR specifi  c 
for H-2K  b  /OVA  257  –  264   were a gift from F. Carbone (University of Melbourne, 
Melbourne, Australia). OT-I mice were also crossed with Thy-1 congenic 
B6.PL-Thy1a/Cy (Thy-1.1) mice (Jackson ImmunoResearch Laboratories) 
and bred to homozygosity, generating OT-I.PL mice. IL-12R     1KO mice 
were obtained by crossing OT-I mice with IL-12R     1KO B6 mice, and 
IFN-IR KO (IFN-IR       /      ) OT-I mice were obtained in a similar way. 
IL-12R     1       /       and IFN-IR       /       DKO OT-I mice were generated via crossing 
the single-receptor KO OT-I mice. The OT-I and OT-I.PL breeding colonies 
were maintained under specifi  c pathogen-free conditions at the University of 
Minnesota. C57BL/6NCr and CD45.1 congenic   “  B6-Ly5.2  ”   mice were pur-
chased from the National Cancer Institute. All experiments involving animals 
were approved by the Institutional Animal Care and Usage Committee at the 
University of Minnesota. Generation of K  b  /OVA tetramers was carried out 
as previously described (  31  ). OVA peptide (OVAp: sequence SIINFEKL) and 
eff  ector K  b  /OVA-reactive cells reported in this study. How-
ever, as previously discussed (  35  ), the 2C TCR ligands used in 
that study were relatively CD8 independent, which may con-
tribute to these divergent outcomes. Further work will be 
needed to determine how the CD8 dependency of individual 
T cell clones impacts their sensitivity at the late eff  ector phase. 
  Our fi  ndings indicating reduced antigen sensitivity of late 
eff  ector cells raises the question of why this would be useful 
for the host. As proposed in the previous two paragraphs, this 
phase may present a restraint on cells that are the most CD8 
dependent. In addition, however, this regulatory mechanism 
may detune eff  ector responsiveness to avoid overstimulation 
and/or potential damage to normal cells through excessive 
production of cytokine (  54  ). Interestingly, others have re-
ported that repeated antigen exposure generates a population 
of CD8  low   T cells (  10  ), which show impaired antigen sensi-
tivity and which have the capacity to restrain responsiveness 
of their CD8  high   counterparts, potentially operating through 
TGF-      production (  55  ). This response to sustained antigen 
encounter might represent a mechanism of locking cells into 
the CD8 down-regulated phase we observe transiently dur-
ing acute antigen exposure. In addition, our data indicated 
that early eff  ector (day 3) OT-I cells respond well to a weak 
agonist ligand, although this reactivity is impaired by day 7 of 
the response (  Fig. 4 C  ). Similarly, previous studies have indi-
cated a brief kinetic   “  window  ”   after CD8 T cell activation, 
during which CTL transiently acquire sensitivity to low-af-
fi  nity ligands, followed by decreased sensitivity of the cells 
(  56  ). The decline in this sensitivity as the response matures 
may ensure that only high affi   nity/avidity CTL responses are 
maintained during the late eff  ector phase. 
  The mechanism of CD8 down-regulation was also studied. 
IFN-I and IL-12 have been shown to be important for the acti-
vation of CTLs (  43  ), and we show that autonomous reactivity 
to IFN-I is required for CD8 down-regulation during LM-
OVA infection (  Fig. 5 and Fig. 6  ). Stimulation of OT-I T cells 
with antigen plus the potent IFN-I inducer poly I:C  –  induced 
CD8 down-regulation (  Fig. 6  ), yet poly I:C alone was unable 
to provoke the response (  Fig. 6  ), suggesting that cells only be-
come susceptible to IFN-I  –  induced CD8 down-regulation af-
ter TCR activation. IFN-I is important in antiviral responses, 
but has also been implicated as a negative factor in LM infec-
tion, causing lymphocytes to be more sensitive to apoptosis and 
impairing resistance of mice to LM infection (  57  –  59  ). At the 
same time, IFN-IR       /       CD8 T cells exhibit slightly reduced 
proliferation after in vivo challenge with LM (unpublished data) 
(  44  ). Despite the observation that IFN-IR       /       OT-Is avoid 
down-regulation of CD8 and tetramer binding, these cells still 
exhibit impaired IFN-      production at day 7 of activation. This 
illustrates the complexity of deciphering the impact of CD8 
down-regulation, compared with other eff   ects of depriving 
CTL of IFN-I signals, especially because expression of IFN-      
may be enhanced by IFN-I under these assay conditions. 
  A related issue is whether IFN-IR plays a direct role on 
CD8 down-regulation, or whether it is indirect; for example, 
the cytokine receptor might enhance overall T cell activation JEM VOL. 204, October 29, 2007 
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staining (Miltenyi MACS system), and then sorted based on Thy-1.1 and CD8 
staining (FACSAria; Becton Dickinson). Purity of sorted cells was      95% by 
postsort analysis. RNA was isolated (Qiagen RNeasy kit), and 8 ng of RNA 
(quantitated using Ribogreen; Invitrogen) was used to synthesize cDNA (using 
the SuperScript III Platinum TwoStep qRT-PCR kit; Invitrogen). Quantita-
tion was performed on 1      l cDNA (equivalent to     400 pg of starting RNA) 
using a Smart Cycler real-time PCR machine (Cepheid). Primers used were 
as follows: CD8      5      left primer, 5     -GTTCTGTCGTGCCAGTCCTT-3     ; 
CD8      3      right primer, 5     -GCCGACAATCTTCTGGTCTC-3     ; CD8      
5      left primer, 5     -CGCTGATCATTTGTGAAACTGTTT-3     ; CD8      3      
right primer, 5     -GAGTGGCCGTCTACTTTTACTGTGT-3     ; GAPDH 5      
left primer, 5     -TGTCTCCTGCGACTTCAACAGC-3     ; GAPDH 3      right 
primer, 5     -TGTAGGCCATGAGGTCCACCAC-3     . Details of the real-time 
PCR conditions used are available upon request. 
  Online supplemental material.     In Fig. S1, the kinetics of OT-I CD8 T cell 
expansion after infection with LM-OVA or VV-OVAp is shown. Fig. S2 shows 
the correlation between CD8 expression levels and OVA/K  b   tetramer staining 
on OT-I CD8 T cells stimulated in vivo with LM-OVA or VV-OVAp. In 
Fig. S3, the expression level of the OT-I TCR was determined at various times 
after in vivo stimulation. Fig. S4 illustrates the reduced IFN-      production capacity 
of day 7 versus day 3 eff  ector OT-I T cells. The online version of this article is 
available at http://www.jem.org/cgi/content/full/jem.20062376/DC1. 
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its variant N6 (sequence SIINFNKL) were synthesized by Invitrogen. All di-
rectly conjugated fl  uorescent antibodies were purchased from BD Biosciences 
or eBioscience. 
  Naive T cell purifi  cation and adoptive transfer.     Inguinal, axillary, bra-
chial, cervical, and mesenteric LNs were harvested from OT-I.PL or receptor 
KO mice. LNs were pooled and disrupted to obtain a single-cell suspension, 
and the cells were enriched for CD8      CD44  low   cells by negative selection us-
ing MACS magnetic cell sorting (Miltenyi Biotec). In brief, cells were coated 
with FITC-labeled antibodies specifi  c for CD4, B220, I-A  b  , and CD44. Anti-
FITC magnetic MicroBeads (Miltenyi Biotech) were added to the cells, 
which were passed over separation columns attached to the MACS magnet. 
The cells that did not bind to the column were collected and were      95% 
CD8      and      0.5% CD44  high  . Enriched cells (10  6  , unless otherwise stated) 
were adoptively transferred i.v. (via the tail vein) into C57BL/6 recipients. 
  Infection and immunization.     The recombinant VV VV-GFP-JAW-OVA 
(VV-OVAp) was provided by J. Yewdell (National Institutes of Health, 
Bethesda, MD). This virus encodes the OVA  257  –  264    –  restricted epitope, fused 
C-terminally to GFP and the transmembrane region of JAW-1. Mice were 
infected i.p. with 5       10  6   PFU of the indicated virus (viral titer was deter-
mined by plaque assays performed on 143B cells). Recombinant LM, which 
encodes full-length OVA (LM-OVA), was a gift from H. Shen (University of 
Pennsylvania, Philadelphia, PA). Infection was performed i.p. at a dose of 10  4   
CFU/mouse. For other immunizations, mice were injected with poly I:C 
(150      g/mouse) with or without SIINFEKL peptide (50      g/mouse) i.v. via 
the tail vein. In some experiments, OT-I.PL cells were adoptively transferred, 
and the host mice were infected with LM-OVA, but the mice were then 
rested for      30 d to allow for generation of an OT-I memory pool. 
  Intracellular cytokine staining after in vitro rechallenge.     Spleen cells 
harvested from adoptively transferred mice were incubated at a concentration 
of 2       10  6   cells/ml in RP-10 with OVAp or N6 peptide (at the indicated 
concentrations) and 1      l GolgiPlug (BD Biosciences) for 3.5 h at 37  °  C. Cells 
were washed and stained with the antibodies to CD8 and CD45.2 and/or 
Thy 1.1 to mark the OT-I and OT-I.PL cells. Cells were fi  xed in Cytofi  x 
buff  er (BD Biosciences) for 15 min at 4  °  C, and permeabilized in saponin-
containing Perm/Wash buff  er (BD Biosciences) for 15 min at 4  °  C before 
staining with (FITC- or PE-conjugated) antibody to IFN-      for 30 min at 
4  °  C. Cells were washed once with Perm/Wash buff  er and once with PBS 
containing 2% FBS. 
  Flow cytometric analysis of transferred cells.     Mice were killed at the in-
dicated times after adoptive transfer and viral or bacterial infection. Spleen cells, 
peritoneal cells, and LN cells (pooled from axillary, brachial, cervical, inguinal, 
and mesenteric nodes) were counted by trypan blue dye exclusion to deter-
mine total viable cell counts, and were stained with the antibodies to CD8, 
CD45.2, and/or Thy 1.1 to detect the transferred OT-I cells. Stained cells 
were analyzed on a FACSCalibur fl  ow cytometer using CellQuest software 
(BD Biosciences) to determine the percentage and total number of OT-I cells 
in the transferred mice. K  b /OVA tetramer staining was performed in the pres-
ence of the enhancing anti-CD8      antibody 53.6.72 or (in Fig. 7) the blocking 
anti-CD8      antibody CT-CD8a. Antibody specifi  c for TCR V     2 (B20.1), 
which binds the OT-I TCR, was included during tetramer staining to simul-
taneously monitor TCR levels. These staining conditions reduce overall tetra-
mer binding, but allow for clearer resolution of changes in tetramer staining. 
  Statistical analysis.     Data was graphed and analyzed using a two-tailed 
Student  ’  s   t   test (GraphPad Prism 3.0 software). Comparisons with a P value of 
     0.05 were considered signifi  cantly diff  erent. 
  Real-time RT-PCR.    Naive OT-I.PL CD8 T cells were adoptively transferred 
into B6.SJL hosts, which were then infected with VV-OVAp, as described in 
Infection and immunization. At the indicated time points after infection, donor 
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